GMI

Isorhamnetin ameliorates insulin resistance, oxidative stress, and inflammation. Isorhamnetin could represent a promising therapeutic agent to treat T2D.

n/a


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *